Literature DB >> 17052454

A stapled BID BH3 helix directly binds and activates BAX.

Loren D Walensky1, Kenneth Pitter, Joel Morash, Kyoung Joon Oh, Scott Barbuto, Jill Fisher, Eric Smith, Gregory L Verdine, Stanley J Korsmeyer.   

Abstract

BAX is a multidomain proapoptotic BCL-2 family protein that resides in the cytosol until activated by an incompletely understood trigger mechanism, which facilitates BAX translocation to mitochondria and downstream death events. Whether BAX is activated by direct contact with select BH3-only members of the BCL-2 family is highly debated. Here we detect and quantify a direct binding interaction between BAX and a hydrocarbon-stapled BID BH3 domain, which triggers the functional activation of BAX at nanomolar doses in vitro. Chemical reinforcement of BID BH3 alpha helicity was required to reveal the direct BID BH3-BAX association. We confirm the specificity of this BH3 interaction by characterizing a stapled BAD BH3 peptide that interacts with antiapoptotic BCL-X(L) but does not bind or activate BAX. We further demonstrate that membrane targeting of stapled BID BH3 optimizes its ability to activate BAX, supporting a model in which BID directly engages BAX to trigger mitochondrial apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052454     DOI: 10.1016/j.molcel.2006.08.020

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  166 in total

1.  Evolving the use of peptides as components of biomaterials.

Authors:  Joel H Collier; Tatiana Segura
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

2.  BH3 domains other than Bim and Bid can directly activate Bax/Bak.

Authors:  Han Du; Jacob Wolf; Blanca Schafer; Tudor Moldoveanu; Jerry E Chipuk; Tomomi Kuwana
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

3.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX.

Authors:  Bonsu Ku; Chengyu Liang; Jae U Jung; Byung-Ha Oh
Journal:  Cell Res       Date:  2010-11-09       Impact factor: 25.617

4.  Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers.

Authors:  Kyoung Joon Oh; Pawan Singh; Kyungro Lee; Kelly Foss; Shinyoub Lee; Minji Park; Steffi Lee; Sreevidya Aluvila; Matthew Park; Puja Singh; Ryung-Suk Kim; Jindrich Symersky; D Eric Walters
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

5.  Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif.

Authors:  Jingzhen Ding; Zhi Zhang; G Jane Roberts; Mina Falcone; Yiwei Miao; Yuanlong Shao; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

6.  Amphipathic tail-anchoring peptide and Bcl-2 homology domain-3 (BH3) peptides from Bcl-2 family proteins induce apoptosis through different mechanisms.

Authors:  Jae-Kyun Ko; Kyoung-Han Choi; Jun Peng; Feng He; Zhi Zhang; Noah Weisleder; Jialing Lin; Jianjie Ma
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

Review 7.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

8.  Application of ring-closing metathesis to Grb2 SH3 domain-binding peptides.

Authors:  Fa Liu; Alessio Giubellino; Philip C Simister; Wenjian Qian; Michael C Giano; Stephan M Feller; Donald P Bottaro; Terrence R Burke
Journal:  Biopolymers       Date:  2011       Impact factor: 2.505

9.  Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.

Authors:  Kazuki Izumi; Eiichi Kodama; Kazuya Shimura; Yasuko Sakagami; Kentaro Watanabe; Saori Ito; Tsuyoshi Watabe; Yukihiro Terakawa; Hiroki Nishikawa; Stefan G Sarafianos; Kazuo Kitaura; Shinya Oishi; Nobutaka Fujii; Masao Matsuoka
Journal:  J Biol Chem       Date:  2008-12-10       Impact factor: 5.157

10.  Hydrogen exchange-mass spectrometry measures stapled peptide conformational dynamics and predicts pharmacokinetic properties.

Authors:  Xiangguo Eric Shi; Thomas E Wales; Carl Elkin; Noriyuki Kawahata; John R Engen; D Allen Annis
Journal:  Anal Chem       Date:  2013-11-14       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.